What Changes for Supplement Brands in Late July 2026

1. The 10% import surcharge ends July 24

The temporary Section 122 surcharge, a 10% duty added to most non-exempt US imports since February 24, 2026, expires by operation of law at 12:01 a.m. EDT on July 24, 2026. Only Congress can extend it, and as of July 21 no extension bill was pending (Trade Act of 1974, Section 122; CBP CSMS #67844987; Nakachi Eckhardt & Jacobson trade-counsel analysis, July 4, 2026, accessed July 9, 2026; status re-checked July 21, 2026).

What changes: a non-exempt Chinese botanical extract entered through July 23 faces roughly 17.5% to 35% in combined duties; entries from 12:01 a.m. EDT on July 24 carry the 7.5% to 25% Section 301 base plus the 12.5% forced-labor Section 301 duty finalized July 23, 2026 (roughly 20% to 37.5% combined). What does not change: Section 301 tariffs from the 2018-2019 trade actions and base MFN duties. One caution on the earlier exemptions: under the new forced-labor layer vitamins remain exempt as entered, but amino acids and CoQ10 are covered for supplement use (that action's chemical exemptions are limited to pharmaceutical applications).

Two cautions before you re-price. First, entry date controls: goods entered before July 24 still pay the surcharge. Second, the successor is now in force: USTR took final action on July 23, 2026 in its forced-labor Section 301 investigations, imposing duties of 10% to 12.5% on imports from 60 economies (12.5% China, 10% India, 10% net-of-MFN EU), applicable to entries on or after 12:01 a.m. eastern time July 24, 2026; goods loaded and in transit before that instant and entered before July 28 are excepted (USTR final-action notice, Dockets USTR-2026-0265/0266, accessed July 24, 2026). Build your landed-cost models on the Section 301 base plus the forced-labor layer; the July 24 surcharge savings are largely offset for covered origins. Our tariff estimator already reflects the expiration automatically.

2. GRAS reform is proposed, not law

Update September 6, 2026: FDA announced a proposed GRAS rule on August 10, 2026, and is seeking public comments under docket FDA-2025-N-3262. If finalized, it would require notices for certain uses of substances in human and animal food. The current notification program is voluntary.

Nothing changes today. But if your formulas rely on self-affirmed ingredients, ask suppliers for their GRAS documentation and note which ingredients have an FDA "no questions" letter versus a self-affirmation file.

3. Amazon's supplement verification is fully in effect

Amazon's third-party verification requirement for dietary supplements took effect on April 2, 2024, and is fully in effect today. Every supplement listing must clear review by an approved Testing, Inspection, and Certification provider. What that review covers depends on the product: high-risk categories such as weight management, sports nutrition, sexual enhancement, and joint health require third-party lab testing, while other supplements are validated against a current cGMP certificate.

The approved-provider list, which includes labs such as NSF, Eurofins, SGS, UL, and Intertek, is short and updates monthly inside Seller Central. Response deadlines are set per listing: read the due date Amazon shows for that listing in Manage Your Compliance (Amazon Seller Central TIC announcement and program FAQ, accessed July 10, 2026).

If Amazon is in your channel plan, budget for TIC verification the way you budget for a certificate of analysis: per SKU, on a real calendar. Our Amazon supplement compliance guide covers the requirement in detail.

4. Ingredient markets are moving in opposite directions

Blanket "supply chain panic" is bad planning. Two current examples make the point.

Omega-3 supply is tightening. Peru's first anchovy season quota for 2026 came in at 1.91 million metric tons, a 36% cut from the roughly 3 million metric tons of early 2025, and analysts warn of fish-oil scarcity risk through the decade (NutraIngredients, April 15, 2026; Rabobank via SeafoodSource, accessed July 9, 2026). Suppliers are building inventory buffers. If fish oil is in your line, talk to your supplier about contract coverage and lead times now, before the next quota announcement.

Creatine is the opposite story. Chinese production capacity expanded sharply, and supplier market analyses report mid-2026 prices roughly half their early-2025 peak (Caloong Chemical price-trend analysis; Guidechem supply-chain report, accessed July 9, 2026). Buyers with creatine SKUs are negotiating from strength this year.

The lesson: price and availability are ingredient-specific. Check your actual bill of materials against current market data before accepting across-the-board increases.